Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
Zynerba Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 23, 2020
Zynerba Pharmaceuticals reported fiscal year 2019 executive compensation information on April 23, 2020.
In 2019, three executives at Zynerba Pharmaceuticals received on average a compensation package of $1.1M, a 26% decrease compared to previous year.
Average pay of disclosed executives at Zynerba Pharmaceuticals
Armando Anido, Chief Executive Officer, received $1.4M in total, which decreased by 32% compared to 2018. 41% of Anido's compensation, or $568K, was in salary. Anido also received $334K in non-equity incentive plan, $413K in option awards, as well as $54K in other compensation.
Terri B. Sebree, President, received a compensation package of $1M, which decreased by 19% compared to previous year. 42% of the compensation package, or $438K, was in salary.
James E. Fickenscher, Chief Financial Officer, earned $824K in 2019, a 25% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 23, 2020.